NO20013741L - Mono-acyloksy-aralkyl-neuromuskul¶re avslappende midler - Google Patents

Mono-acyloksy-aralkyl-neuromuskul¶re avslappende midler

Info

Publication number
NO20013741L
NO20013741L NO20013741A NO20013741A NO20013741L NO 20013741 L NO20013741 L NO 20013741L NO 20013741 A NO20013741 A NO 20013741A NO 20013741 A NO20013741 A NO 20013741A NO 20013741 L NO20013741 L NO 20013741L
Authority
NO
Norway
Prior art keywords
acyloxy
mono
aralkyl
aralkenyl
lower alkyl
Prior art date
Application number
NO20013741A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013741D0 (no
Inventor
Chingmuh Lee
Laszlo Gyermek
Young-Moon Cho
Original Assignee
Newlaxant Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newlaxant Llc filed Critical Newlaxant Llc
Publication of NO20013741D0 publication Critical patent/NO20013741D0/no
Publication of NO20013741L publication Critical patent/NO20013741L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20013741A 1999-02-01 2001-07-31 Mono-acyloksy-aralkyl-neuromuskul¶re avslappende midler NO20013741L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11839299P 1999-02-01 1999-02-01
PCT/US2000/002228 WO2000044377A1 (en) 1999-02-01 2000-01-31 Mono-acyloxy aralkyl neuromuscular relaxants

Publications (2)

Publication Number Publication Date
NO20013741D0 NO20013741D0 (no) 2001-07-31
NO20013741L true NO20013741L (no) 2001-09-19

Family

ID=22378296

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013741A NO20013741L (no) 1999-02-01 2001-07-31 Mono-acyloksy-aralkyl-neuromuskul¶re avslappende midler

Country Status (21)

Country Link
EP (1) EP1150673A4 (es)
JP (1) JP2002535366A (es)
KR (1) KR20010108125A (es)
CN (1) CN1338934A (es)
AR (1) AR022472A1 (es)
AU (1) AU2634900A (es)
BR (1) BR0007863A (es)
CA (1) CA2360790A1 (es)
CO (1) CO5170470A1 (es)
CZ (1) CZ20012780A3 (es)
HK (1) HK1039455A1 (es)
HU (1) HUP0200413A3 (es)
IL (1) IL144249A0 (es)
MX (1) MXPA01007783A (es)
NO (1) NO20013741L (es)
NZ (1) NZ513064A (es)
PE (1) PE20001593A1 (es)
PL (1) PL349099A1 (es)
TR (1) TR200102196T2 (es)
WO (1) WO2000044377A1 (es)
ZA (1) ZA200105882B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204087D0 (en) * 2002-02-21 2002-04-10 Legislator 1563 Ltd Di-ester derivatives as short acting neuromuscular blockers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746964A (en) * 1953-11-02 1956-05-22 Lakeside Lab Inc Dicarboxylic acid esters of nu-alkyl-3-hydroxypiperidine and salts thereof
AT292702B (de) * 1968-12-29 1971-09-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von neuen N-Metyl-piperidin-Derivaten sowie der Säureadditionssalze und der Oniumderivate dieser Verbindungen
US5494898A (en) * 1991-02-13 1996-02-27 Ohmeda Pharmaceutical Products Division Inc. Peptide skeletal muscle relaxants
US5990124A (en) * 1997-10-24 1999-11-23 Gyermek; Laszlo Neuromuscular relaxants

Also Published As

Publication number Publication date
PL349099A1 (en) 2002-07-01
CZ20012780A3 (cs) 2002-01-16
NO20013741D0 (no) 2001-07-31
KR20010108125A (ko) 2001-12-07
HUP0200413A2 (en) 2002-06-29
ZA200105882B (en) 2003-02-18
EP1150673A1 (en) 2001-11-07
AU2634900A (en) 2000-08-18
PE20001593A1 (es) 2001-01-16
IL144249A0 (en) 2002-05-23
EP1150673A4 (en) 2002-04-24
CO5170470A1 (es) 2002-06-27
CA2360790A1 (en) 2000-08-03
AR022472A1 (es) 2002-09-04
TR200102196T2 (tr) 2002-01-21
WO2000044377A1 (en) 2000-08-03
CN1338934A (zh) 2002-03-06
HK1039455A1 (zh) 2002-04-26
JP2002535366A (ja) 2002-10-22
MXPA01007783A (es) 2002-08-20
BR0007863A (pt) 2001-11-06
HUP0200413A3 (en) 2002-11-28
NZ513064A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
NZ246603A (en) Carbamate derivatives and fungicidal compositions thereof
NO20014104L (no) Anvendelse av sulfamatderivater for behandling av impulskontrollsykdommer
AU4437896A (en) Piperidine derivatives having tachykinin antagonist activity
CA2217006A1 (en) Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
NO965209L (no) Substituerte pyrazoler med corticotropin-frigjörende faktor (CRF) antagonist-aktivitet
TR200200416T2 (tr) İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
HU9601568D0 (en) Cyclic amide derivatives as neurokinin antagonists
DE69705829D1 (de) Meta-substituierte phenylsulphonamidderivate
ATE495187T1 (de) Dalda-analoge und ihre verwendung
CA2449679A1 (en) Androstenones
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
NO954328L (no) Nye substituerte 1-fenyl-pyridinyl-benzotriazoler
DK0888337T3 (da) Piperidon-tachykininantagonister
CA2094806A1 (en) Aminosulfonyl urea acat inhibitors
NO20013741L (no) Mono-acyloksy-aralkyl-neuromuskul¶re avslappende midler
NO961168L (no) Nye uretanholdige aminosteroid forbindelser
UA41936C2 (uk) 2-[[1-[4-(4-фторфенокси)бутил]-4-піперидиніл]метиламіно]бензотіазололи, призначені для використання в медицині як антиаритмічні засоби ііі класу, спосіб їх одержання і антиаритмічна композиція
DE69329649D1 (de) Verbesserte antiandrogene
CA2278057A1 (en) Tachykinin antagonists
AU655869B2 (en) An amphoteric tricyclic compound
CA2133186A1 (en) 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
NO950731L (no) Optisk aktive karboksamidderivater
PT912568E (pt) Imidazopiridinas
CA2425164A1 (en) (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application